-+ 0.00%
-+ 0.00%
-+ 0.00%

PRESS RELEASE: SANOFI AND REGENERON’S DUPIXENT APPROVED IN JAPAN FOR CHILDREN AGED 6 TO 11 YEARS WITH BRONCHIAL ASTHMA

Reuters·12/23/2025 06:00:02

Please log in to view news